| References |
Top |
| REF 1 |
Transcriptional regulation of neutral sphingomyelinase 2 in all-trans retinoic acid-treated human breast cancer J Biochem. 2012 Jun;151(6):599-610.
|
| REF 2 |
Interplay between PKC and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation. J Virol. 2011 Mar;85(5):2373-85.
|
| REF 3 |
Stimulation of signal transducer and activator of transcription-1 (STAT1)-dependent gene transcription by lipopolysaccharide and interferon-gamma is regulated by mammalian target of rapamycin. J Biol Chem. 2003 Sep 5;278(36):33637-44.
|
| REF 4 |
Activation of protein kinase C delta by IFN-gamma. J Immunol. 2003 Jul 1;171(1):267-73.
|
| REF 5 |
Von Hippel-Lindau regulates interleukin-32 stability in ovarian cancer cells. Oncotarget. 2017 Jul 17;8(41):69833-69846.
|
| REF 6 |
The von Hippel-Lindau tumour-suppressor protein interaction with protein kinase Cdelta. Biochem J. 2006 Jul 1;397(1):109-20.
|
| REF 7 |
Differential effects of tumor necrosis factor-alpha on protein kinase C isoforms alpha and delta mediate inhibition of insulin receptor signaling. Diabetes. 2002 Jun;51(6):1921-30.
|
| REF 8 |
Retinoic acid mediates degradation of IRS-1 by the ubiquitin-proteasome pathway, via a PKC-dependant mechanism. Oncogene. 2004 Dec 9;23(57):9269-79.
|
